GSK Investigational Site — Yakima, Washington

GSK Investigational Site is a clinical research site located in Yakima, Washington, United States 98902.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

GSK Investigational Site has participated in 10 clinical trials.

Therapeutic areas: Neoplasms, Breast, Major Depressive Disorder (MDD), Thrombocytopaenia.

Sponsors: GlaxoSmithKline, XenoPort, Inc., Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GSK Investigational Site?

GSK Investigational Site has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GSK Investigational Site conducted?

GSK Investigational Site has 10 clinical trials on record. Their work covers Neoplasms, Breast, Major Depressive Disorder (MDD), Thrombocytopaenia.

Is GSK Investigational Site accredited by Crixeo Health?

Yes — GSK Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about GSK Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.